Article Text

Download PDFPDF

281 Health-related quality of life of rare disease patients and care-givers in Hong Kong
  1. Yvette Nga Chung Ng,
  2. Brian Hon Yin Chung,
  3. Claudia Ching Yan Chung
  1. Hong Kong


Background A rare disease (RD) is a disease affecting less than one in 2,000 people. In Hong Kong, one in 67 people is living with one or more RDs. RD patients live with different degrees of life-long physical or intellectual disability and often require special care. Approximately 80% of the RDs are genetic in origin, in which some are with childhood onset. The paediatric RD patients constitute 35% of the whole RD population in Hong Kong.

Objectives To investigate the health-related quality of life (HRQoL) of patients and care-givers in the RD population in Hong Kong.

Methods This was a cross-sectional study between 25 April and 16 October 2020. The EuroQol 5-Dimension 3-Level (EQ-5D-3L), a generic preference-based patient-reported outcome measure instrument, was distributed to the RD patients and care-givers through RD patient groups to describe HRQoL. The five dimensions assessed were mobility, self-care, usual activity, anxiety/depression and pain/discomfort. The three levels represent severity in each dimension, with Level 1 indicating absence of problem and Level 3 indicating extreme problems. The EQ-5D-3L was available in self-complete version, and proxy version for care-givers of patients mentally or physically incapable of reporting. In the proxy version, care-givers reported the HRQoL for both patients and themselves. A reverse crosswalk algorithm was used to generate five-level (EQ-5D-5L) utility scores from EQ-5D-3L profiles with reference to the Hong Kong value set, to allow comparison with the general population. The utility score ranges from 0 (death) to 1 (perfect health), with negative values indicating worse-than-death health states.

Results During the study period, 284 valid and independent responses were collected, including 165 patients from self-complete version and 119 patients and their care-givers from proxy version. The median age of patients and care-givers participated were 32.1 and 42.9, respectively. The mean utility score of patients and care-givers were 0.5207 and 0.7992, both significantly lower than that of the normal population, 0.9186 (p<0.0001). 77 (65%) of the 119 patients from the proxy version were below 18 years old, with a mean utility score of 0.4504. Among all 284 patients, patients able to self-report had a higher mean utility score, 0.5753, than patients requiring a care-giver for reporting, 0.4449. Patients requiring a proxy reported more severe problems in self-care and usual activities dimensions, while their care-givers reported more problems in anxiety/depression dimension. Overall, only 16% of patients and 29% of care-givers had Level 1 in all five dimensions. In contrast, five (3%) patients in self-complete version and 25 (21%) patients in proxy version were reported with negative utility scores, in which two had Level 3 in all five dimensions. Out of the 30 patients with negative utility scores, 93% had no self-care ability, 87% were unable to perform usual activities and 67% were confined to bed.

Conclusions This is the first study in Asia to demonstrate that RD as a group has a negative impact on the HRQoL of both patients and care-givers. It illustrated the impact of RDs on different aspects of quality of life, which warrants exceptional care from policy makers and the society.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.